Menu
Coalition for Affordable Drugs IV LLC v. Pharmacyclics, LLC
Represented patent owner Pharmacyclics to defend against a short-selling hedge fund’s IPR petition against an Orange Book-listed patent on the mantle cell lymphoma treatment IMBRUVICA® (ibrutinib). Obtained a complete denial of institution.
Case IPR2015-01076 (PTAB).